Researchers identified cells likely targeted by COVID-19 virus
On Apr. 22, 2020, researchers at Massachusetts Institute of Technology (MIT); the Ragon Institute of MGH, and Harvard…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics | Vaccine
Biogen, Broad Institute of MIT and Harvard, Partners HealthCare launched consortium to build and share a COVID-19 Biobank
On Apr. 16, 2020, Biogen, Broad Institute of MIT and Harvard, and Partners HealthCare announced a consortium that…
Biogen, Broad Institute of MIT and Harvard, Partners HealthCare consortium build and share COVID-19 biobank
On Apr. 16, 2020, a team of researchers at the McGovern Institute for Brain Research at MIT, the…
Harvard, MIT and Stanford commited to COVID-19 technology licensing principles, maximizing access to innovations
On Apr. 7, 2020, Harvard University, Massachusetts Institute of Technology, and Stanford University announced they had established and…
New IHME COVID-19 forecasts find lower hospital bed need, epidemics starting to peak confirms social distancing works
On Apr. 5, 2020, updated COVID-19 estimates from the Institute for Health Metrics and Evaluation (IHME) found that…
BioAegis accelerated multiple clinical trial submissions for severe COVID-19 pneumonia patients
On Apr. 2, 2020, BioAegis Therapeutics announced that it was preparing to evaluate plasma gelsolin replacement in severe…
Broad Institute’s CLIA-certified testing center began processing COVID-19 patient samples
On Mar. 26, 2020, working in partnership with the Commonwealth of Massachusetts, Massachusetts State Public Health Laboratory, and…
Oxford University COVID-19 study showed that Wuhan travel restrictions prevented wider disease spread
On Mar. 25, 2020, a mobility and epidemiological study from a global consortium of researchers, led by the…
The Simmons Cancer Center joined elite National Comprehensive Cancer Network
On Mar. 24, 2020, the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern announced it had joined…
The Priestley Medal was awarded to JoAnne Stubbe
On Mar. 23 2020, The Priestley Medal was awarded to JoAnne Stubbe by the American Chemical Society “to…
Harvard Bioscience introduced next generation inhalation system to aid in fight against COVID-19
On Mar. 23, 2020, Harvard Bioscience announced that it had launched an innovative technology – known as Accumulated…
Biotechnology | COVID-19 | Diagnostics | Life Science History | Non-Profit Research | Therapeutics | Vaccine
Boston University NEIDL scientists joined international Coronavirus research effort
On Mar. 2, 2020, Boston’s top infectious disease researchers, including scientists from Boston University’s National Emerging Infectious Diseases…
Innovation Pharma provided scientific rationale and clinical development perspectives for Brilacidin as potential Coronavirus treatment
On Mar. 2, 2020, Innovation Pharma provided the scientific rationale and clinical development perspectives for Brilacidin, the Company’s…
Artificial Intelligence | Biotechnology | Disease | Life Science News | Medicine | Non-Profit Research | Therapeutics
Artificial intelligence yielded new antibiotic
On Feb. 20, 2020, using a machine-learning algorithm, researchers at MIT and the Broad Institute of MIT and…
Novo Ventures and the Broad Institute of MIT and Harvard announced the launch of the Novo Broad Greenhouse
On Nov. 19, 2019, Novo Ventures and the Broad Institute of MIT and Harvard announced the launch of…
Vanderbilt Vaccine Center Director James Crow Jr, MD, was awarded half of the Future Insight Prize by Merck KGaA of Germany
On Jul. 9, 2019, Vanderbilt Vaccine Center announced that Director James Crow Jr., MD, had been awarded half…
FUJIFILM opened Life Science Strategic Business Office in Cambridge, Massachusetts
On May 30, 2019, FUJIFILM opened a Life Science Strategic Business Office in Cambridge, Massachusetts to create a…
Massachusetts General Hospital received $200 million to advance research into complex diseases
On Apr. 26, 2019, Massachusetts General Hospital (MGH) announced it had received the largest gift in the hospital’s…
ICON acquired MolecularMD
On Feb. 21, 2019, ICON announced that it had acquired MolecularMD, a molecular diagnostic specialty laboratory that enables…
TESARO was acquired by GSK for $5.1 billion
On Jan. 22, 2019, GlaxoSmithKline acquired TESARO based in Waltham, Massachusetts, for an aggregate cash consideration of approximately…
Takeda Pharmaceutical acquired Shire
On Jan. 8, 2019, Takeda Pharmaceutical announced the completion of its acquisition of Lexington, Massachusetts-based Shire for $62…
AquAdvantage announced FDA approval of first U.S. facility for commercial production of AquAdvantage Salmon
On Apr. 27, 2018, AquaBounty Technologies announced that it had received approval from the U.S. Food and Drug…
Sanofi acquired Bioverativ for $11.6 billion
On Mar. 8, 2018, Sanofi acquired Waltham, Massachusetts-based Bioverativ for for $11.6 billion. Bioverativ’s extended half-life therapies, Eloctate…
Paul G Allen Frontiers Group announced two new Allen Discovery Centers
On Oct. 11, 2017, the Paul G. Allen Frontiers Group announced the creation of two new Allen Discovery…
Washington University received $10 million for DNA sequencing research
On Jun. 21, 2017, McDonnell Genome Institute announced it had received a $10 million from the National Heart,…
Humans began domesticating crops and livestock
On Oct. 31, 2016, scientists reported that humans domestication of crops and livestock are dated to 14000 BCE…
Human Cell Atlas Initiative launched
On Oct. 13, 2016, the Cell Atlas Initiative was launched at a meeting at The Wellcome Trust in…
AquaBounty’s AquAdvantage Salmon approved by Health Canada
On May 20, 2016, AquaBounty Technologies announced that Health Canada had concluded its review of the AquAdvantage Salmon…
Sigma-1 receptor structure was revealed, leading to potential ALS therapeutic agents
On April 28, 2016, Harvard researcher Andrew Kruse and collaborators first revealed the molecular structure of the sigma-1…
The McDonnell Genome Institute received a $60 million from the NIH to study the genetics of common diseases
On Jan. 19, 2016, the McDonnell Genome Institute at Washington University School of Medicine in St. Louis announced…